Cargando…
Safety and Ergogenic Properties of Combined Aminophylline and Ambrisentan in Hypoxia
We hypothesized that concomitant pharmacological inhibition of the endothelin and adenosine pathway is safe and improves exercise performance in hypoxic humans, via a mechanism that does not involve augmentation of blood oxygenation. To test this hypothesis, we established safety and drug interactio...
Autores principales: | Schroeder, Thies, Piantadosi, Claude A., Natoli, Michael J., Autmizguine, Julie, Cohen‐Wolkowieczs, Michael, Hamilton, Karyn L., Bell, Christopher, Klawitter, Jelena, Christians, Uwe, Irwin, David C., Noveck, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947522/ https://www.ncbi.nlm.nih.gov/pubmed/28857147 http://dx.doi.org/10.1002/cpt.860 |
Ejemplares similares
-
Anti-Hypotensive Treatment and Endothelin Blockade Synergistically Antagonize Exercise Fatigue in Rats under Simulated High Altitude
por: Radiloff, Daniel, et al.
Publicado: (2014) -
Effects of lovastatin on breast cancer cells: a proteo-metabonomic study
por: Klawitter, Jelena, et al.
Publicado: (2010) -
Mitochondrial cyclophilin D ablation is associated with the activation of Akt/p70S6K pathway in the mouse kidney
por: Klawitter, Jelena, et al.
Publicado: (2017) -
Ambrisentan for the treatment of pulmonary arterial hypertension
por: Casserly, Brian, et al.
Publicado: (2009) -
Ambrisentan-induced severe asymptomatic thrombocytopenia
por: Kigitovica, Dana, et al.
Publicado: (2020)